Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Document Type
Year range
1.
Actas Dermosifiliogr (Engl Ed) ; 112(2): 118-126, 2021 Feb.
Article in English, Spanish | MEDLINE | ID: covidwho-1064694

ABSTRACT

Researchers the world over are working to find the treatments needed to reduce the negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis of patients. Several drugs that are often used in dermatology are among the potentially useful treatments: ivermectin, antiandrogenic agents, melatonin, and the antimalarial drugs chloroquine and hydroxychloroquine. These and other agents, some of which have proven controversial, are being scrutinized by the scientific community. We briefly review the aforementioned dermatologic drugs and describe the most recent findings relevant to their use against COVID-19.


Subject(s)
COVID-19 Drug Treatment , SARS-CoV-2 , Androgen Antagonists/pharmacology , Androgen Antagonists/therapeutic use , Antimalarials/pharmacology , Antimalarials/therapeutic use , Antioxidants/pharmacology , Antioxidants/therapeutic use , Antiparasitic Agents/pharmacology , Antiparasitic Agents/therapeutic use , COVID-19/mortality , Chloroquine/pharmacology , Chloroquine/therapeutic use , Cinchona/chemistry , Humans , Hydroxychloroquine/pharmacology , Hydroxychloroquine/therapeutic use , Ivermectin/pharmacology , Ivermectin/therapeutic use , Melatonin/pharmacology , Melatonin/therapeutic use , Virus Internalization/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL